Marshall Wace’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.4M Buy
211,695
+51,951
+33% +$344K ﹤0.01% 1593
2025
Q1
$1.46M Buy
159,744
+86,321
+118% +$790K ﹤0.01% 1513
2024
Q4
$771K Sell
73,423
-307,404
-81% -$3.23M ﹤0.01% 1725
2024
Q3
$4.55M Buy
380,827
+48,536
+15% +$580K 0.01% 952
2024
Q2
$1.91M Buy
332,291
+91,843
+38% +$528K ﹤0.01% 1268
2024
Q1
$1.25M Buy
240,448
+49,813
+26% +$259K ﹤0.01% 1358
2023
Q4
$1M Sell
190,635
-74,314
-28% -$392K ﹤0.01% 1221
2023
Q3
$874K Buy
264,949
+194,178
+274% +$641K ﹤0.01% 1299
2023
Q2
$205K Buy
+70,771
New +$205K ﹤0.01% 1812
2022
Q2
Sell
-10,440
Closed -$147K 2723
2022
Q1
$147K Sell
10,440
-164,751
-94% -$2.32M ﹤0.01% 2429
2021
Q4
$2.54M Buy
+175,191
New +$2.54M ﹤0.01% 1532
2021
Q2
Sell
-20,756
Closed -$317K 2136
2021
Q1
$317K Buy
+20,756
New +$317K ﹤0.01% 1800